Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes. - Wikidata - awgldk - TriplyDB

Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.

Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.

http://www.wikidata.org/entity/Q34636137

about

Fever as an important resource for infectious diseases research Entry inhibitors: New advances in HCV treatment The Effect of Small Molecules on Sterol Homeostasis: Measuring 7-Dehydrocholesterol in Dhcr7-Deficient Neuro2a Cells and Human Fibroblasts Hepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Selective inhibition of hepatitis C virus infection by hydroxyzine and benztropine.Repurposing of the antihistamine chlorcyclizine and related compounds for treatment of hepatitis C virus infection.Up-regulation of the ATP-binding cassette transporter A1 inhibits hepatitis C virus infection.Flunarizine prevents hepatitis C virus membrane fusion in a genotype-dependent manner by targeting the potential fusion peptide within E1.A Schisandra-Derived Compound Schizandronic Acid Inhibits Entry of Pan-HCV Genotypes into Human Hepatocytes Betanodavirus-like particles enter host cells via clathrin-mediated endocytosis in a cholesterol-, pH- and cytoskeleton-dependent manner How hepatitis C virus invades hepatocytes: the mystery of viral entry Membrane organization and cell fusion during mating in fission yeast requires multipass membrane protein Prm1 Abl Tyrosine Kinase Regulates Hepatitis C Virus Entry Clinically Approved Ion Channel Inhibitors Close Gates for Hepatitis C Virus and Open Doors for Drug Repurposing in Infectious Viral Diseases.Desmosterol Increases Lipid Bilayer Fluidity during Hepatitis C Virus Infection.Thioridazine inhibits gene expression control of the cell wall signaling pathway (CWI) in the human pathogenic fungus Paracoccidioides brasiliensis.Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome: Current Therapeutic Options and Potential Targets for Novel Therapies.

P2860

Q26748091-A64A6F63-C937-4B8D-BB2E-628F4C4F590A Q26770817-0B400B29-BCDE-4D75-8D52-E065B81892FF Q28834490-F5FBF004-C438-4444-BFC9-272E3A0B31CA Q30386551-9B7E168C-1297-4A7A-B13B-9C887B724CA3 Q33797817-56AC907A-EADD-471B-8EC7-6DD5F3AA1B84 Q34470890-D026EC3B-5F1D-4ECF-8B77-F82A1C846777 Q35125004-1588D389-AA1A-4B67-9D3D-3CD5FE929953 Q35739094-85E0040B-7926-4BD4-BEFF-2A6F4DEB6E55 Q36037497-BB3647BE-5655-426E-9BFF-929C8BC6A23B Q37633666-5A71A40D-5B7A-49BB-B700-E46030CDB162 Q37682499-0043BEE0-3358-4280-8600-042B54115FBA Q37696337-3B08832D-BD0A-49AA-8D5D-6D2C0DEA3714 Q38695072-1ED03EFA-2FF8-454D-A325-019F448400B5 Q38997064-8247058D-9699-4E66-A34D-A65E2784CF7E Q39116776-1364BAC3-871D-4CA8-9965-7788ED32826B Q40763094-C3F1240D-2383-4863-9B18-DFC6CBEAD31E Q43280688-25616EC9-8C35-486A-AECC-CCAF773613B6

P2860

Phenothiazines inhibit hepatitis C virus entry, likely by increasing the fluidity of cholesterol-rich membranes.

http://www.wikidata.org/entity/Q34636137

description

2013 nî lūn-bûn

@nan

2013 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի մարտին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Phenothiazines inhibit hepatit ...... of cholesterol-rich membranes.

@ast

Phenothiazines inhibit hepatit ...... of cholesterol-rich membranes.

@en

Phenothiazines inhibit hepatit ...... of cholesterol-rich membranes.

@nl

type

label

Phenothiazines inhibit hepatit ...... of cholesterol-rich membranes.

@ast

Phenothiazines inhibit hepatit ...... of cholesterol-rich membranes.

@en

Phenothiazines inhibit hepatit ...... of cholesterol-rich membranes.

@nl

prefLabel

Phenothiazines inhibit hepatit ...... of cholesterol-rich membranes.

@ast

Phenothiazines inhibit hepatit ...... of cholesterol-rich membranes.

@en

Phenothiazines inhibit hepatit ...... of cholesterol-rich membranes.

@nl

P1433

Q34636137-BA811CD2-C83D-467A-A47D-B274EDFA82AC

P1476

Q34636137-CCD6426B-5FF7-4A6B-BB40-2F2C98176A8F

P2093

Q34636137-25CF0D0A-31AA-4713-9C67-382FBCC72E4F

Q34636137-5DFB39BF-80A6-46E4-BAEE-E1D22496F6FD

Q34636137-7ECF4BA9-FC8E-4587-853F-C895B205E59E

Q34636137-AA9B35B3-04C4-48D3-B1D8-DB3A3E79F3EE

Q34636137-C8182D59-8BC5-4F91-B471-F8E0CAEBB87C

Q34636137-D33CCC16-7A39-4B0B-A7F2-01351B61B663

P2860

Q34636137-02446656-C4B7-4768-8C5A-3C89FC45C95B

Q34636137-06677F02-A684-41AF-8DB8-56F2323D89AB

Q34636137-06EC82A6-430B-4473-A5B7-52BBA3FDCE09

Q34636137-0C3EDAF9-C706-4355-8044-4CFC7A6374F5

Q34636137-1BFB7EB8-0844-423F-8798-C3B8387ABA86

Q34636137-1C78B7E6-D095-4BE4-B268-92D4FFD21B95

Q34636137-1EC813E2-A542-4DC5-AB40-F2D8641B0F90

Q34636137-24CD2CCA-3017-4D4F-AA2D-9961C10E1A89

Q34636137-2E6DD3B1-BF73-49F2-AF08-DB837DDB1C01

Q34636137-30FFAC5F-8606-4EFA-8424-21799351769B

P304

Q34636137-6D132F4E-A7AF-4B1C-94D1-BE4CB7D41235

P31

Q34636137-B0B441AA-5551-4A2C-852C-E2316F9288EC

P356

Q34636137-105940FA-1408-4C41-BB64-412BF11838F1

P407

Q34636137-7A6B5BB1-B590-4D67-9CE5-77E182A84D90

P433

Q34636137-26D50CD9-8C74-4B27-A830-0FC33609BDB5

P478

Q34636137-CF5DBB16-0683-40FD-920B-AA1C79F7C761

P577

Q34636137-8491A671-B482-48BA-9FE2-3A80ED7E38E8

P5875

Q34636137-29899464-3BCB-4688-8698-2D80C63DB358

P698

Q34636137-E7673C69-55FB-4135-8111-23BC4414CAE0

P932

Q34636137-633B5C88-93C3-4FF3-B96D-1E9B922ED05B

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Phenothiazines inhibit hepatit ...... of cholesterol-rich membranes.

@en

P2093

Ana M Chamoun-Emanuelli

http://www.w3.org/2001/XMLSchema#string

Da Huang

http://www.w3.org/2001/XMLSchema#string

Eve-Isabelle Pecheur

http://www.w3.org/2001/XMLSchema#string

Paul S Cremer

http://www.w3.org/2001/XMLSchema#string

Rudo L Simeon

http://www.w3.org/2001/XMLSchema#string

Zhilei Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Phase fluctuation in phospholipid membranes revealed by Laurdan fluorescence

Flotillins play an essential role in Niemann-Pick C1-like 1-mediated cholesterol uptake.

An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

Unbiased probing of the entire hepatitis C virus life cycle identifies clinical compounds that target multiple aspects of the infection

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

Robust hepatitis C virus infection in vitro.

Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily.

Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras

High-Avidity Monoclonal Antibodies against the Human Scavenger Class B Type I Receptor Efficiently Block Hepatitis C Virus Infection in the Presence of High-Density Lipoprotein

Characterization of Fusion Determinants Points to the Involvement of Three Discrete Regions of Both E1 and E2 Glycoproteins in the Membrane Fusion Process of Hepatitis C Virus

P304

2571-2581

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.02593-12

http://www.w3.org/2001/XMLSchema#string

P407

P433

6

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P577

2013-03-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

236081423

http://www.w3.org/2001/XMLSchema#string

P698

23529728

http://www.w3.org/2001/XMLSchema#string

P932

3716126

http://www.w3.org/2001/XMLSchema#string